dallas tirzepatide class action A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager informed patients Lilly seeks to intervene in

This next-gen makeup product is formulated to give your skin a matte finish that lasts all day long

Medications in this classcommonly known by brand names such as Wegovy, Ozempic, Mounjaro, and Saxendastay in the system much longer than the natural hormone

Med Assoc

Frequently Asked Questions Can HSA funds pay for a medication the FDA has not approved

Undefeated in trial and complex product liability litigation National reach with a personal, boutique-level focus Contingency fee structure: no payment unless we win Over 50 years of compained eperience holding multi-national companies accountable We dont just build cases, we build leverage

Yes, about 23% of women report menstrual changes during the first 16 weeks of tirzepatide treatment